Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Vaccines

  Free Subscription


22.07.2019

4 AIDS
1 Ann Intern Med
1 BMJ
2 Clin Infect Dis
2 Infect Immun
2 J Virol
1 Lancet
2 Pediatr Infect Dis J
1 PLoS Comput Biol
22 Vaccine
4 Virology


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AIDS

  1. DELL'ACQUA R, Galli L, Poli A, Mastrangelo A, et al
    Viro-immunological outcomes after thirteen-valent pneumococcal vaccination in HIV-1 infected subjects on stable virological suppression.
    AIDS. 2019 Jul 10. doi: 10.1097/QAD.0000000000002307.
    PubMed     Text format     Abstract available

  2. DURIER C, Desaint C, Lelievre JD, Silbermann B, et al
    Long-term safety and vaccine-induced seropositivity in healthy volunteers from HIV vaccine trials: a French cohort study.
    AIDS. 2019 Jul 10. doi: 10.1097/QAD.0000000000002310.
    PubMed     Text format     Abstract available

  3. FLYNN PM, Abrams EJ
    Response to correspondence entitled: Perinatal HIV and response to vaccination.
    AIDS. 2019;33:1675-1677.
    PubMed     Text format    

  4. DAUBY N
    Perinatal HIV and response to vaccination.
    AIDS. 2019;33:1674-1675.
    PubMed     Text format    


    Ann Intern Med

  5. WILDER-SMITH A, Barrett A, Vannice K, Hombach J, et al
    Long-Term Protection After Fractional-Dose Yellow Fever Vaccination.
    Ann Intern Med. 2019;171:145-146.
    PubMed     Text format    


    BMJ

  6. ARIE S
    Ebola: calls for second experimental vaccine in DRC after WHO declares emergency.
    BMJ. 2019;366:l4781.
    PubMed     Text format    


    Clin Infect Dis

  7. OEHLER RL
    On Measles, Vaccination, Social Media Activism and How to Win Back Our Role as our Patients' Best Advocates.
    Clin Infect Dis. 2019 Jul 15. pii: 5532609. doi: 10.1093.
    PubMed     Text format     Abstract available

  8. KHAGAYI S, Omore R, Otieno GP, Ogwel B, et al
    Effectiveness of monovalent rotavirus vaccine against hospitalization with acute rotavirus gastroenteritis in Kenyan children.
    Clin Infect Dis. 2019 Jul 20. pii: 5536640. doi: 10.1093.
    PubMed     Text format     Abstract available


    Infect Immun

  9. ROWE HM, Mann B, Iverson A, Poole A, et al
    A Cross-reactive Protein Vaccine Combined with PCV-13 Prevents Streptococcus pneumoniae- and Haemophilus influenzae-mediated Acute Otitis Media.
    Infect Immun. 2019 Jul 15. pii: IAI.00253-19. doi: 10.1128/IAI.00253.
    PubMed     Text format     Abstract available

  10. CHAWLA B, Mahajan B, Oakley M, Majam VF, et al
    Antibody-dependent IFN-gamma-independent sterilizing immunity, induced by a subunit malaria vaccine.
    Infect Immun. 2019 Jul 15. pii: IAI.00236-19. doi: 10.1128/IAI.00236.
    PubMed     Text format     Abstract available


    J Virol

  11. NOTARIO L, Redondo-Anton J, Alari-Pahissa E, Albentosa A, et al
    CD69 targeting enhances anti-Vaccinia virus immunity.
    J Virol. 2019 Jul 17. pii: JVI.00553-19. doi: 10.1128/JVI.00553.
    PubMed     Text format     Abstract available

  12. ABDULHAQQ SA, Wu H, Schell JB, Hammond KB, et al
    Vaccine-mediated Inhibition of the Transporter Associated with Antigen Processing is Insufficient to Induce MHC-E Restricted CD8+ T cells in Nonhuman Primates.
    J Virol. 2019 Jul 17. pii: JVI.00592-19. doi: 10.1128/JVI.00592.
    PubMed     Text format     Abstract available


    Lancet

  13. ROBERT A, Funk S, Kucharski AJ
    The measles crisis in Europe-the need for a joined-up approach.
    Lancet. 2019;393:2033.
    PubMed     Text format    


    Pediatr Infect Dis J

  14. DANIER J, Rivera L, Claeys C, Dbaibo G, et al
    Clinical Presentation of Influenza in Children 6 to 35 Months of Age: Findings From a Randomized Clinical Trial of Inactivated Quadrivalent Influenza Vaccine.
    Pediatr Infect Dis J. 2019;38:866-872.
    PubMed     Text format     Abstract available

  15. EDWARDS K, Lambert PH, Black S
    Narcolepsy and Pandemic Influenza Vaccination: What We Need to Know to be Ready for the Next Pandemic.
    Pediatr Infect Dis J. 2019;38:873-876.
    PubMed     Text format     Abstract available


    PLoS Comput Biol

  16. BULL JJ, Nuismer SL, Antia R
    Recombinant vector vaccine evolution.
    PLoS Comput Biol. 2019;15:e1006857.
    PubMed     Text format     Abstract available


    Vaccine

  17. REID MC, Peebles K, Stansfield SE, Goodreau SM, et al
    Models to predict the public health impact of vaccine resistance: A systematic review.
    Vaccine. 2019 Jul 12. pii: S0264-410X(19)30891.
    PubMed     Text format     Abstract available

  18. DE SERRES G, Billard MN, Gariepy MC, Roy MC, et al
    Nephrotic syndrome following four-component meningococcal B vaccination: Epidemiologic investigation of a surveillance signal.
    Vaccine. 2019 Jul 12. pii: S0264-410X(19)30901.
    PubMed     Text format     Abstract available

  19. SEALE AC, Baker CJ, Berkley JA, Madhi SA, et al
    Vaccines for maternal immunization against Group B Streptococcus disease: WHO perspectives on case ascertainment and case definitions.
    Vaccine. 2019 Jul 11. pii: S0264-410X(19)30890.
    PubMed     Text format     Abstract available

  20. KLEIN NP, Bartlett J, Fireman B, Marks MA, et al
    Long-term effectiveness of zoster vaccine live for postherpetic neuralgia prevention.
    Vaccine. 2019 Jul 10. pii: S0264-410X(19)30882.
    PubMed     Text format     Abstract available

  21. DECKER MD, Greenberg DP, Johnson DR, Pool V, et al
    Randomized study of immune responses to two Tdap vaccines among adolescents primed with DTaP and comparison with results among adolescents primed with DTwP.
    Vaccine. 2019 Jul 10. pii: S0264-410X(19)30893.
    PubMed     Text format     Abstract available

  22. SHELDENKAR A, Lim F, Yung CF, Lwin MO, et al
    Acceptance and uptake of influenza vaccines in Asia: A systematic review.
    Vaccine. 2019 Jul 10. pii: S0264-410X(19)30889.
    PubMed     Text format     Abstract available

  23. ISLAM MT, Chowdhury F, Qadri F, Sur D, et al
    Trials of the killed oral cholera vaccine (Shanchol) in India and Bangladesh: Lessons learned and way forward.
    Vaccine. 2019 Jul 10. pii: S0264-410X(19)30870.
    PubMed     Text format     Abstract available

  24. SI S, Zomer E, Fletcher S, Lee J, et al
    Cost-effectiveness of meningococcal polysaccharide serogroups A, C, W-135 and Y conjugate vaccine in Australian adolescents.
    Vaccine. 2019 Jul 10. pii: S0264-410X(19)30886.
    PubMed     Text format     Abstract available

  25. BRIDGES CB, Watson TL, Nelson NP, Chavez-Torres M, et al
    Challenges with hepatitis B vaccination of high risk adults - A pilot program.
    Vaccine. 2019 Jul 11. pii: S0264-410X(19)30746.
    PubMed     Text format     Abstract available

  26. MAC KEON S, Bentivegna S, Levy EM, Marks MS, et al
    Syngeneic B16-F1 cells are more efficient than allogeneic Cloudman cells as antigen source in DC-based vaccination in the B16-F1 murine melanoma model.
    Vaccine. 2019 Jul 13. pii: S0264-410X(19)30909.
    PubMed     Text format     Abstract available

  27. GOCKO X, Poulteau S, Beyens MN, Bertholon P, et al
    Case report: Recurrent peripheral facial paralysis following two influenza vaccinations in 2009 and 2016.
    Vaccine. 2019 Jul 13. pii: S0264-410X(19)30916.
    PubMed     Text format     Abstract available

  28. ROSBERGER Z, Steben M, Norris T, McFadyen A, et al
    A mixed two-dose vaccination schedule: Not enough evidence to support a policy change in Quebec.
    Vaccine. 2019;37:4421.
    PubMed     Text format    

  29. LEE H, Park SY, Clark A, Debellut F, et al
    Cost-effectiveness analysis of the implementation of a National Immunization Program for rotavirus vaccination in a country with a low rotavirus gastroenteritis-related mortality: A South Korean study.
    Vaccine. 2019 Jul 17. pii: S0264-410X(19)30921.
    PubMed     Text format     Abstract available

  30. WAMBURA G, Mwatondo A, Muturi M, Nasimiyu C, et al
    Rabies vaccine and immunoglobulin supply and logistics: Challenges and opportunities for rabies elimination in Kenya.
    Vaccine. 2019 Jul 17. pii: S0264-410X(19)30659.
    PubMed     Text format     Abstract available

  31. LEHRER AT, Wong TS, Lieberman MM, Johns L, et al
    Recombinant subunit vaccines protect guinea pigs from lethal Ebola virus challenge.
    Vaccine. 2019 Jul 16. pii: S0264-410X(19)30797.
    PubMed     Text format     Abstract available

  32. ZHAO B, Marciniuk K, Gibbs E, Yousefi M, et al
    Therapeutic vaccines for amyotrophic lateral sclerosis directed against disease specific epitopes of superoxide dismutase 1.
    Vaccine. 2019 Jul 16. pii: S0264-410X(19)30935.
    PubMed     Text format     Abstract available

  33. VOLCKMAR J, Knop L, Stegemann-Koniszewski S, Schulze K, et al
    The STING activator c-di-AMP exerts superior adjuvant properties than the formulation poly(I:C)/CpG after subcutaneous vaccination with soluble protein antigen or DEC-205-mediated antigen targeting to dendritic cells.
    Vaccine. 2019 Jul 15. pii: S0264-410X(19)30910.
    PubMed     Text format     Abstract available

  34. DE GROOT C, Musken M, Bleckmann M, Ebensen T, et al
    Novel colloidal associations of soyasaponins and lipid components (DPPC, cholesterol) as potential adjuvants for vaccines.
    Vaccine. 2019 Jul 15. pii: S0264-410X(19)30911.
    PubMed     Text format     Abstract available

  35. SARKISSIAN CA, Alteri CJ, Mobley HLT
    UTI patients have pre-existing antigen-specific antibody titers against UTI vaccine antigens.
    Vaccine. 2019 Jul 15. pii: S0264-410X(19)30922.
    PubMed     Text format     Abstract available

  36. GOODING E, Spiliotopoulou E, Yadav P
    Impact of vaccine stockouts on immunization coverage in Nigeria.
    Vaccine. 2019 Jul 15. pii: S0264-410X(19)30765.
    PubMed     Text format     Abstract available

  37. GILCA V, Sauvageau C, De Serres G
    A mixed vaccination schedule of HPV vaccine induces a 100% seropositivity to all 9 HPV types included in 9vHPV vaccine.
    Vaccine. 2019;37:4422-4423.
    PubMed     Text format    

  38. DAUGHERTY MA, Hinman AR, Cochi SL, Garon JR, et al
    The Global Vaccine Action Plan - insights into its utility, application, and ways to strengthen future plans.
    Vaccine. 2019 Jul 17. pii: S0264-410X(19)30933.
    PubMed     Text format     Abstract available


    Virology

  39. CHUONG C, Bates TA, Weger-Lucarelli J
    Infectious cDNA clones of two strains of Mayaro virus for studies on viral pathogenesis and vaccine development.
    Virology. 2019;535:227-231.
    PubMed     Text format     Abstract available

  40. KIM KH, Lee YT, Park S, Jung YJ, et al
    Neuraminidase expressing virus-like particle vaccine provides effective cross protection against influenza virus.
    Virology. 2019;535:179-188.
    PubMed     Text format     Abstract available

  41. LIU L, Li L, Nanfack A, Mayr LM, et al
    Anti-V2 antibody deficiency in individuals infected with HIV-1 in Cameroon.
    Virology. 2019;529:57-64.
    PubMed     Text format     Abstract available

  42. LIU L, Wang T, Wang M, Tong Q, et al
    Recombinant turkey herpesvirus expressing H9 hemagglutinin providing protection against H9N2 avian influenza.
    Virology. 2019;529:7-15.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: